Table 3.
Full Cohort (N = 30,436) | People with Parkinson’s disease | People without Parkinson’s disease |
---|---|---|
Total enrolled N (% of total) | 22,205 (72.9%) | 8,231 (27.1%) |
Age* (mean (sd) years) | 65.87 (10.08) | 56.67(14.07) |
Sex | ||
Female | 8,683 (38.9%) | 5,501(66.8%) |
Male | 10,813 (48.7%) | 1,705 (20.7%) |
Length of Parkinson’s disease diagnosis* (mean (sd) years) | 6.61 (5.88) | NA |
Full Data Collection | ||
First completion of routine longitudinal assessments: Cross-sectional | ||
Participants (number, percent of total) | 20,099 (90.5%) | 7,198 (87.4%) |
Questionnaires (volume, average per participant in first assessment) | 252,079 (11.35) | 65,027 (7.9) |
Routine longitudinal assessments: Longitudinal | ||
Participants (number, percent of total) | 10,600 (47.7%) | 2,664 (32.3%) |
Questionnaires (volume, average per participant in a subsequent assessments) | 239,461 (10.8) | 42,951 (5.2) |
Repeat assessments per participant (mean (sd)) | 3.7 (2.1) | 3.1 (2.1) |
Ancillary Surveys | ||
Participants (number, percent of total) | 7,726 (34.8%) | 1,174 (14.4%) |
Questionnaires (volume, average per participant) | 50,449 (2.2) | 6,527 (0.8) |
Genetic Sub-Study | ||
Total enrolled (genotype completed) | 5,880 (5,092) | NA |
Note: Cross sectional refers to the first battery of assessments as part of routine longitudinal assessments. ‘Age’ and ‘Length of Parkinson’s disease Diagnosis’ are calculated from time of Fox Insight registration. PRO data as of 01-24-2019. Enrollment in the Genetic Sub-Study as of 03-06-2019.